jiliplay 9.com

Nick Kyrgios has described Jannik Sinner and Iga Swiatek’s positive doping tests as “disgusting” ahead of his return to tennis. The controversial Australian has played only one match in more than two years because of injury but that has not stopped him being an outspoken presence on social media during a difficult few months for the sport. First it was announced in August that Sinner had failed two doping tests in March but was cleared of fault, while in November Swiatek was handed a one-month ban for a failed test caused by contaminated medication. Feels good getting these consecutive days training in the bank man.... Wrist re construction and back out here... blessed..................Without failing any drug tests 🙂‍↕️🙏🏽 be proud kygs doing it the right way 😩😂 pic.twitter.com/J8l21lnTdI — Nicholas Kyrgios (@NickKyrgios) December 5, 2024 Kyrgios has been particularly vociferous in his criticism of Sinner, who could yet face a ban after the World Anti-Doping Agency appealed the finding of no fault or negligence in his case. At a press conference ahead of the Brisbane International, Kyrgios told reporters: “I have to be outspoken about it because I don’t think there’s enough people that are speaking about it. I think people are trying to sweep it under the rug. “I just think that it’s been handled horrifically in our sport. Two world number ones both getting done for doping is disgusting for our sport. It’s a horrible look. “The tennis integrity right now – and everyone knows it, but no one wants to speak about it – it’s awful. It’s actually awful. And it’s not OK.” Kyrgios initially underwent knee surgery in January 2023, returning to action in June of that year, but he played only one match before pulling out of Wimbledon due to a torn ligament in his right wrist. He has not played a competitive match since, and it appeared doubtful that he would be able to return, but the 29-year-old will make his comeback in Brisbane this week. Kyrgios will take on France’s Giovanni Mpetshi Perricard in singles, while he will also team up with Novak Djokovic in a blockbuster doubles pairing. “It’s good to be back,” said Kyrgios. “I honestly never thought I’d be back playing at this level. Even entering an event like this, preparing, doing all the right things. A post shared by Nick Kyrgios (@k1ngkyrg1os) “I’m really excited to just go out there and play, just play tennis. I saw Novak in the gym, playing doubles with him, a lot to be excited about that I’m able to get out there and compete again.” Asked whether he could get back to the same level that saw him reach the Wimbledon final in 2022, Kyrgios said: “I still believe I can, whether or not that’s factual or not. There was another player who was like, ‘You have to be realistic’. That’s not how I am. I always back my ability.” The new tennis season is already under way, with the United Cup team event beginning on Friday. Great Britain, who are weakened by the absence of Jack Draper through injury, begin their campaign against Argentina in Sydney on Monday before facing hosts Australia on Wednesday. That could pit Katie Boulter against fiance Alex De Minaur, with the pair having announced their engagement last week. A post shared by Katie Boulter (@katiecboulter) “Obviously some incredible news from our side, but I think we kind of wanted it to die down a little bit before matches started,” said Boulter of the timing. “My private life is out in the public a little bit at the moment. But, in terms of the stuff that I’m doing on the court, I’ll be doing the best I can every single day to stay in my own little bubble.” Billy Harris has taken Draper’s place, with the British number one facing a race against time to be fit for the Australian Open because of a hip problem. Emma Raducanu is the sixth seed at the ASB Classic in Auckland and will begin her season with a match against Robin Montgomery, while Cameron Norrie takes on another American, Learner Tien, at the Hong Kong Open.Future Leaders of 2025 Emerging Personalities to KnowThe controversial Australian has played only one match in more than two years because of injury but that has not stopped him being an outspoken presence on social media during a difficult few months for the sport. First it was announced in August that Sinner had failed two doping tests in March but was cleared of fault, while in November Swiatek was handed a one-month ban for a failed test caused by contaminated medication. Feels good getting these consecutive days training in the bank man.... Wrist re construction and back out here... blessed..................Without failing any drug tests 🙂‍↕️🙏🏽 be proud kygs doing it the right way 😩😂 — Nicholas Kyrgios (@NickKyrgios) Kyrgios has been particularly vociferous in his criticism of Sinner, who could yet face a ban after the World Anti-Doping Agency appealed the finding of no fault or negligence in his case. At a press conference ahead of the Brisbane International, Kyrgios told reporters: “I have to be outspoken about it because I don’t think there’s enough people that are speaking about it. I think people are trying to sweep it under the rug. “I just think that it’s been handled horrifically in our sport. Two world number ones both getting done for doping is disgusting for our sport. It’s a horrible look. “The tennis integrity right now – and everyone knows it, but no one wants to speak about it – it’s awful. It’s actually awful. And it’s not OK.” Kyrgios initially underwent knee surgery in January 2023, returning to action in June of that year, but he played only one match before pulling out of Wimbledon due to a torn ligament in his right wrist. He has not played a competitive match since, and it appeared doubtful that he would be able to return, but the 29-year-old will make his comeback in Brisbane this week. Kyrgios will take on France’s Giovanni Mpetshi Perricard in singles, while he will also team up with Novak Djokovic in a blockbuster doubles pairing. “It’s good to be back,” said Kyrgios. “I honestly never thought I’d be back playing at this level. Even entering an event like this, preparing, doing all the right things. “I’m really excited to just go out there and play, just play tennis. I saw Novak in the gym, playing doubles with him, a lot to be excited about that I’m able to get out there and compete again.” Asked whether he could get back to the same level that saw him reach the Wimbledon final in 2022, Kyrgios said: “I still believe I can, whether or not that’s factual or not. There was another player who was like, ‘You have to be realistic’. That’s not how I am. I always back my ability.” The new tennis season is already under way, with the United Cup team event beginning on Friday. Great Britain, who are weakened by the absence of Jack Draper through injury, begin their campaign against Argentina in Sydney on Monday before facing hosts Australia on Wednesday. That could pit Katie Boulter against fiance Alex De Minaur, with the pair having announced their engagement last week. “Obviously some incredible news from our side, but I think we kind of wanted it to die down a little bit before matches started,” said Boulter of the timing. “My private life is out in the public a little bit at the moment. But, in terms of the stuff that I’m doing on the court, I’ll be doing the best I can every single day to stay in my own little bubble.” Billy Harris has taken Draper’s place, with the British number one facing a race against time to be fit for the Australian Open because of a hip problem. Emma Raducanu is the sixth seed at the ASB Classic in Auckland and will begin her season with a match against Robin Montgomery, while Cameron Norrie takes on another American, Learner Tien, at the Hong Kong Open.jiliplay 9.com 。

Kongu Nadu Makkal Desiya Katchi (KMDK) general secretary E.R. Eswaran has stressed the urgent need for implementation of the Pandiyar-Punnampuzha scheme to address the growing water crisis in the Kongu region. Speaking to mediapersons on Sunday, following the party’s general body meeting in Sengodampalayam, Erode district, he called for immediate government action to secure the region’s water future. He also raised concerns about water pollution in Erode district, mainly caused by waste from dyeing units being discharged into local water bodies. “This pollution has led to a rise in cancer cases, and the government must find a permanent solution,” he said. He criticised the ban on toddy sales, arguing that lifting the ban would significantly boost farmers’ income. “The government should lift the ban to help farmers improve their livelihood,” he added. Mr. Eswaran also urged the State government to include Kalingarayan’s name in the Athikadavu Avinashi project and called for creation of a separate Gobichettipalayam district. Mr. Eswaran also commented on the Tamilaga Vettri Kazhagam’s first conference, noting the low turnout from the Kongu region. “Just because people watch an actor’s movie doesn’t mean they will follow him into politics,” he stated. On Godavari - Cauvery interlinking, Mr. Easwaran urged the Central government to prioritise the project and criticised the BJP for failing to take concrete steps despite supporting Tamil Nadu’s development. Published - November 24, 2024 09:06 pm IST Copy link Email Facebook Twitter Telegram LinkedIn WhatsApp Reddit Erode / water / rivers / state politics( MENAFN - EIN Presswire) Cataract Surgery Devices And Equipment Global market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033 The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-for a limited time only! LONDON, GREATER LONDON, UNITED KINGDOM, December 20, 2024 /EINPresswire / -- Don't miss The Business Research Company's Early Year-End Sale! Get up to 30% off detailed market research reports-limited time only! What Is Driving The Growth Of The Cataract Surgery Devices And Equipment Market? The cataract surgery devices and equipment market has seen exponential growth in recent years. It is expected to surge from $7.46 billion in 2023 to $8.24 billion in 2024, with a compound annual growth rate CAGR of 10.5%. This growth during the historical period can be attributed to aging population demographics, increasing incidence of cataracts, heightened patient awareness, government initiatives for vision care, as well as increasing healthcare expenditure. What Is Projected For The Cataract Surgery Devices And Equipment Market? The market is expected to witness robust growth in the forecast period, reaching $11.84 billion in 2028 at a CAGR of 9.5%. This anticipated growth momentum can be accredited to a growing focus on outpatient surgery, customized intraocular lenses, value-based healthcare models, global vision care campaigns, global initiatives for eye health and significant strides in AI integration, teleophthalmology, remote consultations, rapid technological innovations, improvements in intraocular lens technology, and surgical techniques, particularly femtosecond laser technology. Sample the report here: What Factors Are Driving The Growth Of The Cataract Surgery Devices And Equipment Market? The rising geriatric population, more prone to developing cataracts as they age, is expected to fuel the growth of the cataract surgery devices and equipment market in the future. For instance, according to the 2021 American Community Survey conducted by The United States Census Bureau, there were 55,892,014 people aged 65 and over in the U.S., representing about 16.8% of the population. With age, the prevalence of cataracts increases, thereby escalating demand for cataract surgery devices due to associated vision impairment. What Are The Key Industry Players And Emerging Trends In The Cataract Surgery Devices And Equipment Market? Major companies operating in the cataract surgery devices and equipment market include Johnson & Johnson Services Inc., Allergan Inc., PhysIOL S.A, Novartis AG, Abbott Laboratories, Alcon Inc., HOYA Corporation, Bausch & Lomb Inc., Carl Zeiss Meditech AG, Topcon Corporation, NIDEK Co. Ltd., Glaukos Corporation, Aurolab Co., OPHTEC BV, DORC International BV, Calhoun Vision Inc., Coburn Technologies Inc., HumanOptics AG, Hanita Lenses Ltd., Lenstec Inc., CRISTALENS SL, and EyeKon Medical Inc., among others. In developing innovative products, such as the VERITAS Vision System, these companies aim to improve surgical accuracy and outcomes. Designed to enhance patient safety, surgeon efficiency, and comfort, the VERITAS Vision System was launched by Johnson & Johnson Vision in July 2021. It utilizes hybrid fluidics technology and White star technology to facilitate cataract surgery with more stability and less surge, thereby improving surgical outcomes. Buy the full report here: How Is The Global Cataract Surgery Devices And Equipment Market Segmented? The market is broadly segmented: 1 By Type: Intraocular Lens IOL, Ophthalmic viscoelastic device OVD, Phacoemulsification Equipment, Femtosecond Laser Equipment. 2 By Surgery Type: Extracapsular Cataract Extraction, Phacoemulsification, Femtosecond Laser, Other Surgery Types. 3 By Application: Ophthalmology Centers, Hospitals, Clinics. What Are The Regional Insights Into The Cataract Surgery Devices And Equipment Market? In 2023, North America was the largest player in the global cataract surgery devices and equipment market, closely followed by Asia-Pacific. The regions analyzed in the report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. Browse more similar reports- Ophthalmic Devices Global Market Report 2024 Ophthalmic Medical Lasers Global Market Report 2024 Macular Degeneration Treatment Global Market Report 2024 The Business Research Company has published over 15000+ reports in 27 industries across 60+ geographies. Our exceptional reports, built on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders, provide valuable insights into potential opportunities and strategies. Contact us at The Business Research Company: Americas: +1 3156230293 Asia: +44 2071930708 Europe: +44 2071930708 Email us at ... Follow us on LinkedIn: YouTube: Global Market Model: global-market-model Oliver Guirdham The Business Research Company +44 20 7193 0708 email us here Visit us on social media: Facebook X LinkedIn Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above. MENAFN19122024003118003196ID1109014324 Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

IRVING, Texas , Dec. 10, 2024 /PRNewswire/ -- The Board of Directors of Caterpillar Inc. (NYSE: CAT) voted today to maintain the quarterly dividend of one dollar and forty-one cents ($1.41) per share of common stock, payable Feb. 20, 2025 , to shareholders of record at the close of business on Jan. 21, 2025 .

Nick Kyrgios says positive tests for duo are ‘disgusting’ and ‘a horrible look’

Farmland Partners: Diversification Benefits And An Improving Dividend ProfileSip, Savor and Sleigh at Belmont Park’s Winter Wonder Festival in San Diego

CO2 Energy Transition Corp. Announces Closing of Previously Announced IPO and Full Exercise of Over-allotment Option, Raising $69 Million in Gross Proceeds

Triumph Gold (CVE:TIG) Stock Price Up 35.3% – Still a Buy?